COSCIENS Biopharma Third Quarter 2024 Earnings: US$1.85 loss per share (vs US$3.41 loss in 3Q 2023) [Yahoo! Finance]
COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs
COSCIENS Biopharma Announces Change to Board of Directors
COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director [Yahoo! Finance]
COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director [Financial Post (Toronto, Ontario, Canada)]